NSPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
InspireMD Inc (NSPR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, improving net income, and positive gross margin trends indicate potential for long-term value. Additionally, the recent analyst rating of 'Buy' with a $6 price target suggests significant upside potential from the current pre-market price of $1.71. While there are no immediate proprietary trading signals or news catalysts, the technical indicators and financial performance support a favorable long-term investment decision.
The MACD is positive at 0.0188, indicating bullish momentum, while the RSI of 67.72 is neutral, suggesting no overbought or oversold conditions. The stock is trading near its pivot level of 1.754, with resistance at 1.86 and support at 1.648. Moving averages are converging, indicating a potential breakout. Overall, the technical indicators lean slightly bullish.
Revenue growth of 39.39% YoY in Q3
Gross margin improvement of 49.72% YoY.
Analyst rating of 'Buy' with a $6 price target, indicating significant upside potential.
Lack of recent news or event-driven catalysts.
No significant hedge fund or insider trading activity.
Negative net income, though improving YoY.
In Q3 2025, InspireMD reported a 39.39% YoY increase in revenue to $2,523,000, a 61.06% YoY improvement in net income to -$12,708,000, and a 6.25% YoY increase in EPS to -0.17. Gross margin improved significantly by 49.72% YoY to 34.24%. These metrics indicate strong growth trends despite ongoing losses.
Maxim initiated coverage with a 'Buy' rating and a $6 price target, suggesting strong confidence in the stock's future performance.
